A 42-year-old schoolteacher began GLP-1 therapy for obesity and Type 2 diabetes. Within months, her appetite dropped sharply.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results